CME/CPE/MOC Credit Deadline
Statements of credit must be claimed online after the meeting using either the Interactive Program or the App. Attendees will be required to complete a short evaluation for every session for which credit is claimed. Attendees must attend each selected session in its entirety to receive CME/CPE/MOC credit. Partial credit is not available.
CME Accreditation Statement for Physicians
The Infectious Diseases Society of America (IDSA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.
IDSA designates this other activity (internet live course and internet enduring material activity) for a maximum of 185.5 AMA PRA Category 1 Credits™. The core IDWeek sessions are designated for 174.5 credit hours and premeeting workshops are an additional 11. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity enables the participant to earn up to 181.5 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
IDWeek 2020 physician participation information will be shared with ABIM through ACCME PARS.
Credit for Pharmacists
The continuing education activities for pharmacists have been developed through a joint providership of ProCE, Inc. and the Infectious Diseases Society of America (IDSA). ProCE, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Pharmacy CE will be offered for both live and on-demand sessions. The total available hours will be announced soon. ACPE Universal Activity Numbers will be assigned and available to participants prior to the conference for the live (simulive) and on-demand knowledge-based and application-based sessions (initial release date October 21-25, 2020). This conference is acceptable for up to TBD contact hours (TBD CEUs) in states that recognize ACPE providers. The registration fee covers the cost of CE credits. CE Statements of Completion will be issued by the Infectious Diseases Society of America (IDSA) at the conclusion of the conference. Participants must complete an evaluation for each session they attended to receive pharmacy CE credit. The deadline for completing the evaluations for the live (simulive) CE sessions is Monday, December 7, 2020. ProCE will upload all IDWeek CPE credits to NABP CPE Monitor accounts between December 9 and December 16, 2020 (for live/simulive CE sessions), and within 60 days of completion (for on-demand sessions).
In accordance with the ACCME Standards for Commercial Support, IDSA must provide balance, objectivity, and scientific rigor in all sponsored educational activities accredited for CME. The intent of the disclosure(s) is to provide the audience with information on which they can make their own independent judgments pertaining to program content.
Therefore, IDSA requires all faculty to disclose significant, relevant financial relationships with which they or a spouse/partner have, or have had, within the past 12 months with companies or commercial supporters of any products/services that is related to the research being presented at IDWeek (for example, employee, grants, research support, speaker, sponsors, stockholder, etc.). In addition to verbal and written disclosures, faculty are required to provide on the first slide of PowerPoint presentations, any significant financial interest(s)/relationship(s) or that there is ‘Nothing to disclose.’
Commercial Support Statement
IDSA follows and supports the ACCME guidelines for commercial support.
Resolution of Personal Conflicts of Interest
It is the policy of IDSA that faculty resolve any conflicts of interest prior to IDWeek.
IDWeek faculty are requested to agree, to the following methods of resolving conflicts of interest(s) prior to the beginning of IDWeek:
- If participating in the development of program content, to refrain from developing those components of the meeting that support or promote any financial relationship(s).
- To disclose to the audience prior to IDWeek, any additional financial relationship(s).
- If invited to review abstracts, to refrain from peer reviewing abstracts containing research to which the respective faculty have contributed.
- If trade names of products and/or services are used, to use trade names from several companies, not just trade names from a single company.